The findings of the current study demonstrate that the lack of PER2 expression is associated with an aggressive phenotype and acquired drug resistance in HCC cell models, which involves regulation of epithelial-mesenchymal transition (EMT) and changes in mitochondrial plasticity. This evidence concerns the gene PER2 and hepatocellular carcinoma.